AAAAAA

   
Results: 1-7 |
Results: 7

Authors: BOEHM JC SMIETANA JM SORENSON ME GARIGIPATI RS GALLAGHER TF SHELDRAKE PL BRADBEER J BADGER AM LAYDON JT LEE JC HILLEGASS LM GRISWOLD DE BRETON JJ CHABOTFLETCHER MC ADAMS JL
Citation: Jc. Boehm et al., 1-SUBSTITUTED 4-ARYL-5-PYRIDINYLIMIDAZOLES - A NEW CLASS OF CYTOKINE SUPPRESSIVE DRUGS WITH LOW 5-LIPOXYGENASE AND CYCLOOXYGENASE INHIBITORY POTENCY, Journal of medicinal chemistry, 39(20), 1996, pp. 3929-3937

Authors: BARONE FC HILLEGASS LM TZIMAS MN SCHMIDT DB FOLEY JJ WHITE RF PRICE WJ FEUERSTEIN GZ CLARK RK GRISWOLD DE SARAU HM
Citation: Fc. Barone et al., TIME-RELATED CHANGES IN MYELOPEROXIDASE ACTIVITY AND LEUKOTRIENE B-4 RECEPTOR-BINDING REFLECT LEUKOCYTE INFLUX IN CEREBRAL FOCAL STROKE, Molecular and chemical neuropathology, 24(1), 1995, pp. 13-30

Authors: RABINOVICI R BUGELSKI PJ ESSER KM HILLEGASS LM VERNICK J FEUERSTEIN G
Citation: R. Rabinovici et al., ARDS-LIKE LUNG INJURY PRODUCED BY ENDOTOXIN IN PLATELET-ACTIVATING FACTOR-PRIMED RATS, Journal of applied physiology, 74(4), 1993, pp. 1791-1802

Authors: GRISWOLD DE HILLEGASS LM BRETON JJ ESSER KM ADAMS JL
Citation: De. Griswold et al., DIFFERENTIATION IN-VIVO OF CLASSICAL NONSTEROIDAL ANTIINFLAMMATORY DRUGS FROM CYTOKINE SUPPRESSIVE ANTIINFLAMMATORY DRUGS AND OTHER PHARMACOLOGICAL CLASSES USING MOUSE-TUMOR NECROSIS FACTOR-ALPHA PRODUCTION, Drugs under experimental and clinical research, 19(6), 1993, pp. 243-248

Authors: GRISWOLD DE HILLEGASS LM WHITE JR
Citation: De. Griswold et al., PHARMACOLOGICAL EVALUATION OF LEUKOTRIENE BIOSYNTHESIS AND INFLAMMATION IN AN ADOPTIVE MODEL OF PERITONEAL ANAPHYLAXIS IN THE MOUSE, Drug development research, 30(2), 1993, pp. 83-90

Authors: RABINOVICI R BUGELSKI PJ ESSER KM HILLEGASS LM GRISWOLD DE VERNICK J FEUERSTEIN G
Citation: R. Rabinovici et al., TUMOR-NECROSIS-FACTOR-ALPHA MEDIATES ENDOTOXIN-INDUCED LUNG INJURY INPLATELET-ACTIVATING FACTOR-PRIMED RATS, The Journal of pharmacology and experimental therapeutics, 267(3), 1993, pp. 1550-1557

Authors: SMITH EF GRISWOLD DE EGAN JW HILLEGASS LM SMITH RAG HIBBS MJ GAGNON RC
Citation: Ef. Smith et al., REDUCTION OF MYOCARDIAL REPERFUSION INJURY WITH HUMAN SOLUBLE COMPLEMENT RECEPTOR TYPE-1 (BRL-55730), European journal of pharmacology, 236(3), 1993, pp. 477-481
Risultati: 1-7 |